'Small cell lung' diaporamas de présentation

Cancer-Associated Thrombosis: What you need to know

Cancer-Associated Thrombosis: What you need to know. Anne McLeod. Objectives. To discuss the risk of thrombosis in cancer patients To discuss signs and symptoms of thrombosis To discuss treatment of thrombosis in cancer pts. Why should you care about CAT?.

1.2k views • 42 slides

1.15k views • 24 slides

435 views • 22 slides

WHAT ARE THE MOST SERIOUS ADVERSE EVENTS DURING AND AFTER RADIATION THERAPY?

WHAT ARE THE MOST SERIOUS ADVERSE EVENTS DURING AND AFTER RADIATION THERAPY?. Bhadrasain Vikram, MD. GLIOBLASTOMA Stupp, NEJM 352:987-96, 2005. > Grade 3 non-heme toxicity in 31%. Most common: Fatigue & other constitutional symptoms Rashes & other skin effects Infection Effects on vision

339 views • 14 slides

Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis

To evaluate the efficacy and safety of Icotinib in the treatment of advanced Non-small Cell Lung Cancer (NSCLC).

107 views • 10 slides

Global Non-small Cell Lung Cancer Therapeutics Market 2015 Industry Growth, Overview, Analysis, Share and Trends

218 views • 6 slides

Research Report- Serine-Threonine Protein Kinase(ATR or EC 2.7.11.1) - Pipeline Review, H1 2017

Report outlays comprehensive information on the Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or EC 2.7.11.1) targeted therapeutics.

49 views • 4 slides

Effect of pulmonary wedge resection on Ia stage non-small cell lung cancer of elderly patients, its effect on serum anti

To observe the short-term clinical effect of pulmonary wedge resection in the treatment of primary Non-Small Cell Lung Cancer (NSCLC) and its effect on levels of anti-survivin antibody, Hsp90u03b1 and CEA in serum of patients

45 views • 4 slides